190 related articles for article (PubMed ID: 28951111)
1. Registry-based randomized controlled trials merged the strength of randomized controlled trails and observational studies and give rise to more pragmatic trials.
Mathes T; Buehn S; Prengel P; Pieper D
J Clin Epidemiol; 2018 Jan; 93():120-127. PubMed ID: 28951111
[TBL] [Abstract][Full Text] [Related]
2. Registry-based randomised controlled trials: conduct, advantages and challenges-a systematic review.
Shiely F; O Shea N; Murphy E; Eustace J
Trials; 2024 Jun; 25(1):375. PubMed ID: 38863017
[TBL] [Abstract][Full Text] [Related]
3. Defining key design elements of registry-based randomised controlled trials: a scoping review.
Karanatsios B; Prang KH; Verbunt E; Yeung JM; Kelaher M; Gibbs P
Trials; 2020 Jun; 21(1):552. PubMed ID: 32571382
[TBL] [Abstract][Full Text] [Related]
4. No differences were found between effect estimates from conventional and registry-based randomized controlled trials.
Mathes T; Klaßen P; Pieper D
J Clin Epidemiol; 2019 Jan; 105():80-91. PubMed ID: 30257186
[TBL] [Abstract][Full Text] [Related]
5. "Nothing to lose and the possibility of gaining": a qualitative study on the feasibility and acceptability of registry-based randomised controlled trials among cancer patients and clinicians.
Prang KH; Karanatsios B; Zhang A; Verbunt E; Wong HL; Wong V; Gately L; Tran B; Gibbs P; Kelaher M
Trials; 2023 Feb; 24(1):92. PubMed ID: 36747274
[TBL] [Abstract][Full Text] [Related]
6. Paper II: thematic framework analysis of registry-based randomized controlled trials provided insights for designing trial ready registries.
Krause KR; Tay J; Douglas WA; Sammy A; Baba A; Goren K; Thombs BD; Howie AH; Oskoui M; Frøbert O; Trakadis Y; Little J; Potter BK; Butcher NJ; Offringa M
J Clin Epidemiol; 2023 Jul; 159():330-343. PubMed ID: 37146660
[TBL] [Abstract][Full Text] [Related]
7. Registry-Based Pragmatic Trials in Heart Failure: Current Experience and Future Directions.
Lund LH; Oldgren J; James S
Curr Heart Fail Rep; 2017 Apr; 14(2):59-70. PubMed ID: 28247180
[TBL] [Abstract][Full Text] [Related]
8. Paper I: Heterogeneous use of registry data for participant identification and primary outcome ascertainment is found in registry-based randomized controlled trials: A scoping review.
Baba A; Tay J; Sammy A; Douglas WA; Goren K; Krause KR; Howie AH; Little J; Oskoui M; Taljaard M; Thombs BD; Potter BK; Butcher NJ; Offringa M
J Clin Epidemiol; 2023 Jul; 159():289-299. PubMed ID: 37146658
[TBL] [Abstract][Full Text] [Related]
9. Registry randomised trials: a methodological perspective.
Doherty DA; Tong SYC; Reilly J; Shrapnel J; McDonald S; Ahern S; Harris I; Tam CS; Brennan AL; Hodgson C; Wilcox L; Balagurunathan A; Butcher BE; Reid CM
BMJ Open; 2023 Mar; 13(3):e068057. PubMed ID: 36858472
[TBL] [Abstract][Full Text] [Related]
10. Randomized controlled trials and neurosurgery: the ideal fit or should alternative methodologies be considered?
Mansouri A; Cooper B; Shin SM; Kondziolka D
J Neurosurg; 2016 Feb; 124(2):558-68. PubMed ID: 26315006
[TBL] [Abstract][Full Text] [Related]
11. Opportunities and barriers for the use of Australian cancer registries as platforms for randomized clinical trials.
Yan MK; Adler NR; Heriot N; Shang C; Zalcberg JR; Evans S; Wolfe R; Mar VJ
Asia Pac J Clin Oncol; 2022 Aug; 18(4):344-352. PubMed ID: 34811922
[TBL] [Abstract][Full Text] [Related]
12. Registry-based randomized controlled trials- what are the advantages, challenges, and areas for future research?
Li G; Sajobi TT; Menon BK; Korngut L; Lowerison M; James M; Wilton SB; Williamson T; Gill S; Drogos LL; Smith EE; Vohra S; Hill MD; Thabane L;
J Clin Epidemiol; 2016 Dec; 80():16-24. PubMed ID: 27555082
[TBL] [Abstract][Full Text] [Related]
13. Clinical registries data quality attributes to support registry-based randomised controlled trials: A scoping review.
Prang KH; Karanatsios B; Verbunt E; Wong HL; Yeung J; Kelaher M; Gibbs P
Contemp Clin Trials; 2022 Aug; 119():106843. PubMed ID: 35792338
[TBL] [Abstract][Full Text] [Related]
14. Commentary: On the levels of patient selection in registry-based randomized controlled trials.
Lasch F; Weber K; Koch A
Trials; 2019 Feb; 20(1):100. PubMed ID: 30717778
[TBL] [Abstract][Full Text] [Related]
15. The cohort multiple randomized controlled trial design: a valid and efficient alternative to pragmatic trials?
van der Velden JM; Verkooijen HM; Young-Afat DA; Burbach JP; van Vulpen M; Relton C; van Gils CH; May AM; Groenwold RH
Int J Epidemiol; 2017 Feb; 46(1):96-102. PubMed ID: 27118559
[TBL] [Abstract][Full Text] [Related]
16. Premature trial discontinuation often not accurately reflected in registries: comparison of registry records with publications.
Alturki R; Schandelmaier S; Olu KK; von Niederhäusern B; Agarwal A; Frei R; Bhatnagar N; Hooft L; von Elm E; Briel M
J Clin Epidemiol; 2017 Jan; 81():56-63. PubMed ID: 27614277
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
